Notably, some antinuclear antibodies frequently encountered in patients with rheumatic diseases (e.g., anti-centromere and speckled) can coexist with PBC-specific ANA antibodies, contributing to generate a controversial fluorescent pattern [27]. Here, BTG3 is linked to rheumatic disorder.